These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [A study on ceftazidime in the perinatal period].
    Author: Takase Z, Miyoshi T, Fujiwara M, Nakayama M, Shirafuji H.
    Journal: Jpn J Antibiot; 1986 Aug; 39(8):2273-9. PubMed ID: 3540357.
    Abstract:
    Ceftazidime (CAZ), a new cephem antibiotic with high activity against Gram-negative bacteria, has been investigated for use in mothers in perinatal period, and the results obtained are summarized below. Into maternal serum, umbilical cord serum and amniotic fluid, CAZ showed good transfer after intravenous administration of 1 g or 2 g into mothers, and no adverse effect appeared in their neonates. The CAZ is a very useful antibiotic for the prophylaxis and the treatment of perinatal infections at a dose level of 1-2 g per day.
    [Abstract] [Full Text] [Related] [New Search]